메뉴 건너뛰기




Volumn 7, Issue 10, 2008, Pages 975-977

Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT; FLUDROXYCORTIDE; IMMUNOGLOBULIN G; ISOTRETINOIN; KERATOLYTIC AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

EID: 59049096325     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (12)
  • 1
    • 33846950349 scopus 로고    scopus 로고
    • Cutaneous side-effects in patients with rheumatic disease during application of tumour necrosis factor-alpha antagonists
    • Lee HH, Song IH, Friedrich M, Gauliard A, et al. Cutaneous side-effects in patients with rheumatic disease during application of tumour necrosis factor-alpha antagonists. Br J Dermatol. 2007;156:486-491.
    • (2007) Br J Dermatol , vol.156 , pp. 486-491
    • Lee, H.H.1    Song, I.H.2    Friedrich, M.3    Gauliard, A.4
  • 3
    • 33847142837 scopus 로고    scopus 로고
    • Onset of psoriasis during treatment with TNF-alpha antagonists: A report of 3 cases [6]
    • DOI 10.1001/archderm.143.2.270
    • Ubriani R, Van Voorhees AS. Onset of psoriasis during treatment with TNF-alpha antagonists: a report of 3 cases. Arch Dermatol. 2007;143:270-272. (Pubitemid 46294603)
    • (2007) Archives of Dermatology , vol.143 , Issue.2 , pp. 270-272
    • Ubriani, R.1    Van Voorhees, A.S.2
  • 4
    • 33847389242 scopus 로고    scopus 로고
    • Complications and Adverse Reactions in the Use of Newer Biologic Agents
    • DOI 10.1016/j.sder.2006.12.002, PII S108556290600112X, Complications and Adverse Events
    • Callen JP. Complications and adverse reactions in the use of newer biologic agents. Semin Cutan Med Surg. 2007;26:6-14 (Pubitemid 46349778)
    • (2007) Seminars in Cutaneous Medicine and Surgery , vol.26 , Issue.1 , pp. 6-14
    • Callen, J.P.1
  • 5
    • 33846100586 scopus 로고    scopus 로고
    • Tumor necrosis factor inhibitor-induced pustular psoriasis?
    • DOI 10.1016/j.jaad.2006.09.029, PII S0190962206025941
    • Heymann WR. Tumor necrosis factor inhibitor - induced pustular psoriasis? J Am Acad Dermatol. 2007;56:327-329. (Pubitemid 46074257)
    • (2007) Journal of the American Academy of Dermatology , vol.56 , Issue.2 , pp. 327-329
    • Heymann, W.R.1
  • 6
    • 39949085766 scopus 로고    scopus 로고
    • Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: Report on five cases
    • Mössner R, Thaci D, Mohr J, et al. Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases. Arch Dermatol Res. 2008;300:101-105.
    • (2008) Arch Dermatol Res , vol.300 , pp. 101-105
    • Mössner, R.1    Thaci, D.2    Mohr, J.3
  • 8
    • 33846999640 scopus 로고    scopus 로고
    • Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: A case series
    • Cohen JD, Bournerias I, Buffard V, et al. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol. 2007;34:247-249.
    • (2007) J Rheumatol , vol.34 , pp. 247-249
    • Cohen, J.D.1    Bournerias, I.2    Buffard, V.3
  • 9
    • 35348914628 scopus 로고    scopus 로고
    • Cutaneous adverse reaction to infliximab: Report of psoriasis developing in 3 patients
    • Severs GA, Lawlor TH, Purcell SM, et al. Cutaneous adverse reaction to infliximab: report of psoriasis developing in 3 patients. Cutis. 2007;80:231-237.
    • (2007) Cutis , vol.80 , pp. 231-237
    • Severs, G.A.1    Lawlor, T.H.2    Purcell, S.M.3
  • 10
    • 37549005087 scopus 로고    scopus 로고
    • Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: First 120 cases from the literature including a series of six new patients
    • Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1-14.
    • (2008) Am J Clin Dermatol , vol.9 , pp. 1-14
    • Wollina, U.1    Hansel, G.2    Koch, A.3
  • 11
    • 42749088023 scopus 로고    scopus 로고
    • Onset or exacerbation of cutaneous psoriasis during TNF-α antagonist therapy
    • in press [cited 2008 April 20] doi:10.1016/j.jbspin.2007.06.011. Available at
    • Wendling D, Balblanc JC, Briançon D, et al. Onset or exacerbation of cutaneous psoriasis during TNF-α antagonist therapy. Joint Bone Spine. 2008 in press [cited 2008 April 20] doi:10.1016/j.jbspin.2007.06.011. Available at: http://www.sciencedirect.com.chekov.evms.edu/science?-ob=ArticleURL&- udi=B6W90-4RTCMVX-1&-user=960061&-rdoc=1&-fmt=&-orig= search&-sort=d&view=c&-acct=C000049388&-version= 1&-urlVersion=0&-userid=960061&md5=c62feebfa2ff5eaa26e7c1b54e863556.
    • (2008) Joint Bone Spine
    • Wendling, D.1    Balblanc, J.C.2    Briançon, D.3
  • 12
    • 48849085127 scopus 로고    scopus 로고
    • Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-TNFα therapy
    • in press [cited 2008 April 20] doi:10.1136/ard.2007.087288. Available at
    • Harrison MJ, Dixon WG, Watson KD, et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-TNFα therapy. Ann Rheum Dis. 2008 in press [cited 2008 April 20] doi:10.1136/ard.2007.087288. Available at:http://ard.bmj.com/cgi/rapidpdf/ard.2007.087288v1?maxtoshow=&HITS= 10&hits=10&RESULTFORMAT=&author1=harrison+mj&andorexactfulltext= and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype= HWCIT.
    • (2008) Ann Rheum Dis
    • Harrison, M.J.1    Dixon, W.G.2    Watson, K.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.